1Pan XR,Li GW,Hu YH,Wang JX,Yang WY,An ZX,Hu ZX,Lin J,Xiao JZ,Cao HB,Liu PA,Jiang XG,Jiang YY,Wang JP,Zheng H,Zhang H,Bennett PH,Howard BV.Effects of Diet and Exercise in Preventing NIDDM in People with Impaired Glucose Tolerance.The Da Qing IGT and Diabet
2Knowler WC,Barrett-Connor E,Fowler SE,Hamman RF,Lachin JM,Walker EA,Nathan DM; Diabetes Prevention Program Research Group.Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin Diabetes Prevention Program Research Group[J].
3The Diabetes Control and Complications Trial Research Group.The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus [J].N Engl J Med,1993; 329(14):977-86.
4ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.Major Outcomes in Moderately Hypercholesterolemic,Hypertensive Patients Randomized to Pravastatin Vs Usual Care:The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart
5Hansson L,Iindholm LH,Niskanen L.Effect of ACE-I Compared with Conventional Therapy on Cardiovascular Morbidity and Mortality in Hypertension.The Captopril Prevention Project (CAPPP) randomized trial.Lancet,1999; 353:611
6Feldt-Rasmussen U,Schleusener H,Carayon P.Meta-Analysis Evaluation of the Impact of Thyrotropin Receptor Antibodies on Long Term Remission After Medical Therapy of Graves' Disease.J Clin Endocrinol Metab,1994; 78(1):98-102.
7Glucose Tolerance and Mortality:Comparison Of WHO and American Diabetes Association Diagnostic Criteria.The DECODE Study Group.European Diabetes Epidemiology Group.Diabetes Epidemiology:Collaborative Analysis of Diagnostic Criteria in Europe [J].Lancet,19
8Lindstrom J,Louheranta A,Mannelin M,Rastas M,Salminen V,Eriksson J,Uusitupa M,Tuomilehto J; Finnish Diabetes Prevention Study Group.The Finnish Diabetes Prevention Study (DPS):Lifestyle Intervention and 3-Year Results on Diet and Physical Activity [J].Dia
9Surks MI,Ortiz E,Daniels GH,Sawin CT,Col NF Cobin RH,Franklyn JA,Hershman JM,Burman KD,Denke MA,Gorman C,Cooper RS,Weissman N.Subclinical Thyroid Disease:Scientific Review and Guidelines for Diagnosis and Management.[J].JAMA,2004,291:228-238.
10Yang WY,Lin LX,Qi JW,Yu ZQ,Pei HC,He GF.Yang ZJ,Wang F,Li GW,Pan XR.The prevention effcect of acarbose and Metformin on the IGTpopulation from becoming diabetes mellitus:a 3-year multicentral prospective study.Chinese Journal of Endocrinology and Metuboli
8Heikes KE, Eddy DM, Arondekar B, et al. Diabetes risk calculator: a simple tool for detecting undiagnosed diabetes and pre-diabetes. Diabetes Care,2008,31 : 1040-1045.
9Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group1 Reduction in the Inci-dence of Type 2 Diabetes with Lifestyle Intervention or Metformin Diabetes Prevention Program Research Group. N Engl J Med, 2002 ; 346 (6) : 393-403.
10National Task Force on The Prevention and Treatment of Obesity. Overw eight, obesity and health risk. Areh lnern Med, 2000;160 (7) :898-904.
